Harbour Investments’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-265
| Closed | -$1.27K | – | 3672 |
|
|
2024
Q4 | $1.27K | Hold |
265
| – | – | ﹤0.01% | 3121 |
|
|
2024
Q3 | $1.24K | Hold |
265
| – | – | ﹤0.01% | 3049 |
|
|
2024
Q2 | $1.5K | Hold |
265
| – | – | ﹤0.01% | 2893 |
|
|
2024
Q1 | $1.09K | Hold |
265
| – | – | ﹤0.01% | 2913 |
|
|
2023
Q4 | $1.12K | Hold |
265
| – | – | ﹤0.01% | 2802 |
|
|
2023
Q3 | $1.15K | Hold |
265
| – | – | ﹤0.01% | 2675 |
|
|
2023
Q2 | $1.75K | Hold |
265
| – | – | ﹤0.01% | 2578 |
|
|
2023
Q1 | $1.8K | Hold |
265
| – | – | ﹤0.01% | 2581 |
|
|
2022
Q4 | $1.96K | Hold |
265
| – | – | ﹤0.01% | 2521 |
|
|
2022
Q3 | $3K | Hold |
265
| – | – | ﹤0.01% | 2365 |
|
|
2022
Q2 | $3K | Buy |
+265
| New | +$3K | ﹤0.01% | 2365 |
|
|
2021
Q4 | $4K | Sell |
265
-2,356
| -90% | -$35.6K | ﹤0.01% | 2269 |
|
|
2021
Q3 | $45K | Buy |
2,621
+46
| +2% | +$790 | ﹤0.01% | 1834 |
|
|
2021
Q2 | $55K | Buy |
2,575
+330
| +15% | +$7.05K | ﹤0.01% | 1767 |
|
|
2021
Q1 | $34K | Buy |
+2,245
| New | +$34K | ﹤0.01% | 1905 |
|